Skip to content

High-density Electroencephalograph Assisted Neuromodulation of Abnormal Networks in Mild Cognitive Impairment: An Exploratory Cross Paired Study

High-density Electroencephalograph Assisted Neuromodulation of Abnormal Networks in Mild Cognitive Impairment: An Exploratory Cross Paired Study

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500102479
Enrollment
Unknown
Registered
2025-05-15
Start date
2025-06-01
Completion date
Unknown
Last updated
2025-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive impairment

Interventions

Group A:Repetitive Transcranial Magnetic Stimulation, rTMS. First carry out 28 days of true stimulation, followed by 5 weeks of washout, and then conduct 28 days of sham stimulation.
Group B:Repetitive Transcranial Magnetic Stimulation, rTMS . First carry out 28 days of sham stimulation, followed by 5 weeks of washout, and then conduct 28 days of true stimulation.

Sponsors

Zhongshan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age between 50 and 80 years, with an educational level above primary school. 2. A score of >= 18 on the Mini-Mental State Examination (MMSE), with a clinical diagnosis of mild cognitive impairment. 3. No clinical seizures in the two days prior to high-density electroencephalography (EEG) monitoring, and no consumption of caffeine, nicotine, alcohol, medications, or illicit drugs within 24 hours before the experiment, with adequate sleep. 4. Right-handedness as determined by the Chinese handedness assessment criteria. 5. Normal hearing on initial physical examination.

Exclusion criteria

Exclusion criteria: 1. Individuals who have previously received treatments such as transcranial direct current stimulation, repetitive transcranial magnetic stimulation, trigeminal nerve stimulation, vagus nerve stimulation, or deep brain stimulation, or those with implanted cardiac pacemakers or other metallic devices. 2. Presence of skull defects, or progressive neurological diseases such as brain tumors or encephalitis. 3. Uncontrolled seizures, or a history of status epilepticus within the past six months. 4. Severe medical comorbidities, or pregnancy. 5. Severe psychiatric disorders such as major depression, or auditory or language impairments that preclude cooperation in completing the trial and assessments. 6. Structural abnormalities on imaging that are associated with epilepsy. 7. History of alcohol abuse or drug misuse. 8. Other patients deemed by the investigators to require exclusion.

Design outcomes

Primary

MeasureTime frame
Phase Locking Value,PLV;

Secondary

MeasureTime frame
MMSE;Montreal Cognitive Assessment Score, MoCA;

Countries

China

Contacts

Public ContactJing Ding

Zhongshan Hospital, Fudan University

ding.jing@zs-hospital.sh.cn+86 135 0191 7091

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026